Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie E Flerlage

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Blood|September 8, 2022
Radiotherapy is here to stayJamie E Flerlage
Journal of the National Comprehensive Cancer Network : JNCCN|July 2, 2021
Improving Care for All Pediatric Patients With Hodgkin LymphomaJamie E Flerlage
Journal of Palliative Medicine|May 1, 2015
Methylnaltrexone for Opioid-Induced Constipation in Children and Adolescents and Young Adults with Progressive Incurable Cancer at the End of LifeJamie E Flerlage, Justin N Baker
Blood|June 14, 2018
The management of Hodgkin lymphoma in adolescents and young adults: burden of disease or burden of choice?Jamie E Flerlage, Monika L Metzger, Nickhill Bhakta
Journal of Pediatric Hematology/Oncology|December 19, 2023
Proceedings and Abstracts From the Fifth International Symposium on Childhood, Adolescent, and Young Adult Hodgkin Lymphoma (ISCAYAHL) MeetingJamie E Flerlage, Monica Palese, Christine Mauz-Koerholz, et al.
Cancer Chemotherapy and Pharmacology|November 13, 2016
Pharmacokinetics, immunogenicity, and safety of weekly dosing of brentuximab vedotin in pediatric patients with Hodgkin lymphomaJamie E Flerlage, Monika L Metzger, Jianrong Wu, et al.
Leukemia|September 14, 2021
Clinical and biological aspects of myeloid leukemia in Down syndromeAustin C Boucher, Kenneth J Caldwell, John D Crispino, et al.
Pediatric Blood & Cancer|May 18, 2024
A systematic literature review of clinical evidence and treatment burden in newly diagnosed high-risk pediatric patients with classical Hodgkin lymphomaJamie E Flerlage, Christine Waters-Banker, Michelle Fanale, et al.
Pediatric Blood & Cancer|August 21, 2019
Brentuximab vedotin as consolidation after hematopoietic cell transplant for relapsed Hodgkin lymphoma in pediatric patientsJamie E Flerlage, Xinyu von Buttlar, Matthew Krasin, et al.
Leukemia & Lymphoma|March 10, 2025
Patient and care partner perspectives on treatment decision-making in nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): a Global nLPHL One Working Group (GLOW) studyAjay Major, Monica Palese, Anna Jones, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Blood|September 8, 2022
Radiotherapy is here to stayJamie E Flerlage
Journal of the National Comprehensive Cancer Network : JNCCN|July 2, 2021
Improving Care for All Pediatric Patients With Hodgkin LymphomaJamie E Flerlage
Journal of Palliative Medicine|May 1, 2015
Methylnaltrexone for Opioid-Induced Constipation in Children and Adolescents and Young Adults with Progressive Incurable Cancer at the End of LifeJamie E Flerlage, Justin N Baker
Blood|June 14, 2018
The management of Hodgkin lymphoma in adolescents and young adults: burden of disease or burden of choice?Jamie E Flerlage, Monika L Metzger, Nickhill Bhakta
Journal of Pediatric Hematology/Oncology|December 19, 2023
Proceedings and Abstracts From the Fifth International Symposium on Childhood, Adolescent, and Young Adult Hodgkin Lymphoma (ISCAYAHL) MeetingJamie E Flerlage, Monica Palese, Christine Mauz-Koerholz, et al.
Cancer Chemotherapy and Pharmacology|November 13, 2016
Pharmacokinetics, immunogenicity, and safety of weekly dosing of brentuximab vedotin in pediatric patients with Hodgkin lymphomaJamie E Flerlage, Monika L Metzger, Jianrong Wu, et al.
Leukemia|September 14, 2021
Clinical and biological aspects of myeloid leukemia in Down syndromeAustin C Boucher, Kenneth J Caldwell, John D Crispino, et al.
Pediatric Blood & Cancer|May 18, 2024
A systematic literature review of clinical evidence and treatment burden in newly diagnosed high-risk pediatric patients with classical Hodgkin lymphomaJamie E Flerlage, Christine Waters-Banker, Michelle Fanale, et al.
Pediatric Blood & Cancer|August 21, 2019
Brentuximab vedotin as consolidation after hematopoietic cell transplant for relapsed Hodgkin lymphoma in pediatric patientsJamie E Flerlage, Xinyu von Buttlar, Matthew Krasin, et al.
Leukemia & Lymphoma|March 10, 2025
Patient and care partner perspectives on treatment decision-making in nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): a Global nLPHL One Working Group (GLOW) studyAjay Major, Monica Palese, Anna Jones, et al.
Pageof 5